A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study

por Hsu, Lewis L., Sarnaik, Sharada, Williams, Suzan, Amilon, Carl, Wissmar, Jenny, Berggren, Anders
Publicado 2018